Efficacy and safety of bevacizumab treatment for refractory brain edema: Case report

OBJECTIVE: This retrospective study investigated the efficacy and safety of bevacizumab treatment for refractory brain edema. METHODS: Between March 2009 and December 2015, bevacizumab was used to treat 59 cases of brain metastatic patients with refractory brain edema. The median dose of bevacizumab...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Medicine (Baltimore)
Hlavní autoři: Meng, Xiangying, Zhao, Rugang, Shen, Ge, Dong, Dapeng, Ding, Lijuan, Wu, Shikai
Médium: Artigo
Jazyk:Inglês
Vydáno: Wolters Kluwer Health 2017
Témata:
5700
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5682776/
https://ncbi.nlm.nih.gov/pubmed/29095257
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000008280
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky